- Multiple myeloma
- Advanced breast cancer
- Advanced ovarian cancer
- Polycythemia vera

Melieva 2mg
| MRP | : |
|
| Price | : | ₹1,150.00 |
| You Save | : | ₹2,068.00 (64.26%) |
25 Tablet(s) In A Bottle
Melieva 2mg Tablet contains melphalan as its active ingredient. This medication is classified as an anticancer agent and falls under the category of alkylating agents. It is utilized in the treatment of multiple myeloma, which is a type of bone marrow cancer. Additionally, it is prescribed for advanced breast and ovarian cancer. Furthermore, it is indicated for the treatment of polycythemia vera, a condition that leads to an increased number of red blood cells, resulting in thicker blood and a higher risk of blood clots. The medication functions by decreasing the production of abnormal cells in the body.
You should not use this injection if you have an allergy to melphalan or any of its other components. It is important to inform your doctor if you have recently undergone radiotherapy or chemotherapy for cancer, or if you have any kidney issues. This medicine should not be taken if you are pregnant or planning to become pregnant. Notify your physician if you have received a vaccination recently or are planning to get vaccinated. If you experience any rash, lumps, or hives on your skin, swelling of the face, eyelids, or lips, sudden wheezing, or chest tightness after taking this medication, contact your doctor immediately.